The In Vitro Diagnostics (IVD) Quality Control market was valued at US$ xx in 2023. The market for In Vitro Diagnostics (IVD) Quality Control is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. The report offers detailed coverage of In Vitro Diagnostics (IVD) Quality Control industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading In Vitro Diagnostics (IVD) Quality Control by geography. The report splits the market size, by volume and value, on the basis of application type and geography. In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global In Vitro Diagnostics (IVD) Quality Control market are discussed. The market is segmented by types: Quality Control Products Quality Assurance Services Data Management Solutions It can be also divided by applications: Clinical Chemistry Immunochemistry Hematology Molecular Diagnostics Others And this report covers the historical situation, present status and the future prospects of the global In Vitro Diagnostics (IVD) Quality Control market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America. Finally, the report provides detailed profile and data information analysis of leading company. Bio-Rad Laboratories Thermo Fisher Scientific Randox Laboratories Roche Diagnostics Abbott Diagnostics Helena Laboratories Seracare Life Sciences Technopath Clinical Diagnostics Sun Diagnostics Zeptometrix Corporation ISOLAB Sysmex Corporation Fortress Diagnostics Meril Life Sciences Multiplicom Future Diagnostics Solutions Surmodics Report Includes: - xx data tables and xx additional tables - An overview of global In Vitro Diagnostics (IVD) Quality Control market - An detailed key players analysis across regions - Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031 - Insights into regulatory and environmental developments - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the In Vitro Diagnostics (IVD) Quality Control market - Profiles of major players in the industry, including Bio-Rad Laboratories, Thermo Fisher Scientific, Randox Laboratories, Roche Diagnostics, Abbott Diagnostics..... Research objectives To study and analyze the global In Vitro Diagnostics (IVD) Quality Control consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031. To understand the structure of In Vitro Diagnostics (IVD) Quality Control market by identifying its various subsegments. Focuses on the key global In Vitro Diagnostics (IVD) Quality Control manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years. To analyze the In Vitro Diagnostics (IVD) Quality Control with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of In Vitro Diagnostics (IVD) Quality Control submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents Global In Vitro Diagnostics (IVD) Quality Control Market Report 2024, Forecast to 2031 1 Scope of the Study 1.1 In Vitro Diagnostics (IVD) Quality Control Introduction 1.2 Research Programs 1.3 Analysis of Macroeconomic Indicators 1.4 Years Considered 1.5 Methodology 1.6 Data Source 1.7 Research Objectives 2 In Vitro Diagnostics (IVD) Quality Control Industry Overview 2.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size (Million USD) Comparison by Regions (2024-2031) 2.1.1 In Vitro Diagnostics (IVD) Quality Control Global Main Region Market Analysis 2.2 Market Analysis by Type 2.2.1 Quality Control Products 2.2.2 Quality Assurance Services 2.2.3 Data Management Solutions 2.3 Market Analysis by Application 2.3.1 Clinical Chemistry 2.3.2 Immunochemistry 2.3.3 Hematology 2.3.4 Molecular Diagnostics 2.3.5 Others 2.4 Global In Vitro Diagnostics (IVD) Quality Control Revenue, Sales and Market Share by Manufacturer 2.4.1 Global In Vitro Diagnostics (IVD) Quality Control Sales and Market Share by Manufacturer (2019-2023) 2.4.2 Global In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Manufacturer (2019-2023) 2.4.3 Global In Vitro Diagnostics (IVD) Quality Control Industry Concentration Ratio (CR5 and HHI) 2.4.4 Top 5 In Vitro Diagnostics (IVD) Quality Control Manufacturer Market Share 2.4.5 Top 10 In Vitro Diagnostics (IVD) Quality Control Manufacturer Market Share 2.4.6 Date of Key Manufacturers Enter into In Vitro Diagnostics (IVD) Quality Control Market 2.4.7 Key Manufacturers In Vitro Diagnostics (IVD) Quality Control Product Offered 2.4.8 Mergers & Acquisitions Planning 2.5 In Vitro Diagnostics (IVD) Quality Control Historical Development Overview 2.6 Market Dynamics 2.6.1 Market Opportunities 2.6.2 Market Risk 2.6.3 Market Driving Force 2.6.4 Porter's Five Forces Analysis 2.7 Coronavirus Disease 2019 (Covid-19): In Vitro Diagnostics (IVD) Quality Control Industry Impact 2.7.1 How the Covid-19 is Affecting the In Vitro Diagnostics (IVD) Quality Control Industry 2.7.2 In Vitro Diagnostics (IVD) Quality Control Business Impact Assessment - Covid-19 2.7.3 Market Trends and In Vitro Diagnostics (IVD) Quality Control Potential Opportunities in the COVID-19 Landscape 2.7.4 Measures / Proposal against Covid-19 3 Related Market Analysis 3.1 Related Market Overview 3.2 Macro Analysis of Upstream Markets 3.3 Key Players in Related Markets 3.4 Related Markets Trend Analysis 4 Global In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Regions 4.1 Global In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Regions 4.1.1 Global In Vitro Diagnostics (IVD) Quality Control Sales and Market Share by Regions (2019-2023) 4.1.2 Global In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Regions (2019-2023) 4.2 Europe In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 4.3 APAC In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 4.4 North America In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 4.5 South America In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 4.6 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5 Europe In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Countries 5.1 Europe In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Countries 5.1.1 Europe In Vitro Diagnostics (IVD) Quality Control Revenue by Countries (2019-2023) 5.1.2 Germany In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.1.3 UK In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.1.4 France In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.1.5 Russia In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.1.6 Italy In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.1.7 Spain In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 5.2 Europe In Vitro Diagnostics (IVD) Quality Control Revenue (Value) by Manufacturers (2019-2023) 5.3 Europe In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 5.4 Europe In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Application (2019-2023) 6 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Countries 6.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Countries 6.1.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Revenue by Countries (2019-2023) 6.1.2 China In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.1.3 Japan In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.1.4 Korea In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.1.5 India In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.1.6 Southeast Asia In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.1.7 Australia In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 6.2 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Revenue (Value) by Players (2019-2023) 6.3 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 6.4 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Application (2019-2023) 7 North America In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Countries 7.1 North America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Countries 7.1.1 North America In Vitro Diagnostics (IVD) Quality Control Revenue by Countries (2019-2023) 7.1.2 United States In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 7.1.3 Canada In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 7.1.4 Mexico In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 7.2 North America In Vitro Diagnostics (IVD) Quality Control Revenue (Value) by Players (2019-2023) 7.3 North America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 7.4 North America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Application (2019-2023) 8 South America In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Countries 8.1 South America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Countries 8.1.1 South America In Vitro Diagnostics (IVD) Quality Control Revenue by Countries (2019-2023) 8.1.2 Brazil In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 8.2 South America In Vitro Diagnostics (IVD) Quality Control Revenue (Value) by Players (2019-2023) 8.3 South America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 8.4 South America In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Application (2019-2023) 9 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Market Size Categorized by Countries 9.1 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Countries 9.1.1 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Revenue by Countries (2019-2023) 9.1.2 GCC Countries In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 9.1.3 Turkey In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 9.1.4 Egypt In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 9.1.5 South Africa In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2019-2023) 9.2 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Revenue (Value) by Players (2019-2023) 9.3 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 9.4 Middle East and Africa In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Application (2019-2023) 10 Global In Vitro Diagnostics (IVD) Quality Control Market Segment by Type 10.1 Global In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2019-2023) 10.2 Global In Vitro Diagnostics (IVD) Quality Control Market Forecast by Type (2024-2031) 10.3 Quality Control Products Revenue Growth Rate 10.4 Quality Assurance Services Revenue Growth Rate 10.5 Data Management Solutions Revenue Growth Rate 11 Global In Vitro Diagnostics (IVD) Quality Control Market Segment by Application 11.1 Global In Vitro Diagnostics (IVD) Quality Control Revenue Market Share by Application (2019-2023) 11.2 Global In Vitro Diagnostics (IVD) Quality Control Market Forecast by Application (2024-2031) 11.3 Clinical Chemistry Revenue Growth Rate (2015-2025) 11.4 Immunochemistry Revenue Growth Rate (2015-2025) 11.5 Hematology Revenue Growth Rate (2015-2025) 11.6 Molecular Diagnostics Revenue Growth Rate (2015-2025) 11.7 Others Revenue Growth Rate (2015-2025) 12 Market Forecast for In Vitro Diagnostics (IVD) Quality Control 12.1 Global In Vitro Diagnostics (IVD) Quality Control Market Size Forecast (2024-2031) 12.2 In Vitro Diagnostics (IVD) Quality Control Market Forecast by Regions (2024-2031) 12.3 Europe In Vitro Diagnostics (IVD) Quality Control Revenue Market Forecast (2024-2031) 12.4 APAC In Vitro Diagnostics (IVD) Quality Control Revenue Market Forecast (2024-2031) 12.5 North America In Vitro Diagnostics (IVD) Quality Control Revenue Market Forecast (2024-2031) 12.6 South America In Vitro Diagnostics (IVD) Quality Control Revenue Market Forecast (2024-2031) 12.7 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control Revenue Market Forecast (2024-2031) 13 Analysis of In Vitro Diagnostics (IVD) Quality Control Industry Key Vendors 13.1 Bio-Rad Laboratories 13.1.1 Company Details 13.1.2 Product Information 13.1.3 Bio-Rad Laboratories In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.1.4 Main Business Overview 13.1.5 Bio-Rad Laboratories News 13.2 Thermo Fisher Scientific 13.2.1 Company Details 13.2.2 Product Information 13.2.3 Thermo Fisher Scientific In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.2.4 Main Business Overview 13.2.5 Thermo Fisher Scientific News 13.3 Randox Laboratories 13.3.1 Company Details 13.3.2 Product Information 13.3.3 Randox Laboratories In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.3.4 Main Business Overview 13.3.5 Randox Laboratories News 13.4 Roche Diagnostics 13.4.1 Company Details 13.4.2 Product Information 13.4.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.4.4 Main Business Overview 13.4.5 Roche Diagnostics News 13.5 Abbott Diagnostics 13.5.1 Company Details 13.5.2 Product Information 13.5.3 Abbott Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.5.4 Main Business Overview 13.5.5 Abbott Diagnostics News 13.6 Helena Laboratories 13.6.1 Company Details 13.6.2 Product Information 13.6.3 Helena Laboratories In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.6.4 Main Business Overview 13.6.5 Helena Laboratories News 13.7 Seracare Life Sciences 13.7.1 Company Details 13.7.2 Product Information 13.7.3 Seracare Life Sciences In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.7.4 Main Business Overview 13.7.5 Seracare Life Sciences News 13.8 Technopath Clinical Diagnostics 13.8.1 Company Details 13.8.2 Product Information 13.8.3 Technopath Clinical Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.8.4 Main Business Overview 13.8.5 Technopath Clinical Diagnostics News 13.9 Sun Diagnostics 13.9.1 Company Details 13.9.2 Product Information 13.9.3 Sun Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.9.4 Main Business Overview 13.9.5 Sun Diagnostics News 13.10 Zeptometrix Corporation 13.10.1 Company Details 13.10.2 Product Information 13.10.3 Zeptometrix Corporation In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.10.4 Main Business Overview 13.10.5 Zeptometrix Corporation News 13.11 ISOLAB 13.11.1 Company Details 13.11.2 Product Information 13.11.3 ISOLAB In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.11.4 Main Business Overview 13.11.5 ISOLAB News 13.12 Sysmex Corporation 13.12.1 Company Details 13.12.2 Product Information 13.12.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.12.4 Main Business Overview 13.12.5 Sysmex Corporation News 13.13 Fortress Diagnostics 13.13.1 Company Details 13.13.2 Product Information 13.13.3 Fortress Diagnostics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.13.4 Main Business Overview 13.13.5 Fortress Diagnostics News 13.14 Meril Life Sciences 13.14.1 Company Details 13.14.2 Product Information 13.14.3 Meril Life Sciences In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.14.4 Main Business Overview 13.14.5 Meril Life Sciences News 13.15 Multiplicom 13.15.1 Company Details 13.15.2 Product Information 13.15.3 Multiplicom In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.15.4 Main Business Overview 13.15.5 Multiplicom News 13.16 Future Diagnostics Solutions 13.16.1 Company Details 13.16.2 Product Information 13.16.3 Future Diagnostics Solutions In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.16.4 Main Business Overview 13.16.5 Future Diagnostics Solutions News 13.17 Surmodics 13.17.1 Company Details 13.17.2 Product Information 13.17.3 Surmodics In Vitro Diagnostics (IVD) Quality Control Revenue and Gross Margin (2019-2023) 13.17.4 Main Business Overview 13.17.5 Surmodics News 14 Research Findings and Conclusion 15 Appendix